CF102
CF102-211LD
Phase 2 small_molecule completed
Quick answer
CF102 for Non-alcoholic Steatohepatitis (NASH) is a Phase 2 program (small_molecule) at Can-Fite BioPharma with 1 ClinicalTrials.gov record(s).
Program details
- Company
- Can-Fite BioPharma
- Indication
- Non-alcoholic Steatohepatitis (NASH)
- Phase
- Phase 2
- Modality
- small_molecule
- Status
- completed